Q2 2026 cbdMD Inc Earnings Call Transcript

May 14, 2026 / 08:20 PM GMT

Release Date Price: $0.8103 (+1.82%)

Transcript 10-Q

Key Points

Positve

cbdMD Inc (YCBD) reported a 19% year-over-year increase in net sales, reaching $5.6 million.
The company's core business, excluding Bluebird Botanicals, showed significant growth, with the highest quarterly revenue since December 2023.
The acquisition of Bluebird Botanicals is expected to become a positive contributor to both revenue and earnings in the third quarter.
The company is strategically investing in the CMS Substance Access pathway, which could provide significant long-term opportunities.
cbdMD Inc (YCBD) has regained full NYSE American continued listing compliance, strengthening its financial position.

Negative

Gross margin decreased to 58% from 62% in the prior year, primarily due to a shift in revenue mix and increased costs from state-level requirements.
The acquisition of Bluebird Botanicals was a drag on earnings in the second quarter due to transition costs and integration expenses.
The company reported a loss from operations of approximately $801,000, compared to a loss of $486,000 in the prior-year period.
State-level regulatory changes have created ongoing packaging changes, repacking costs, and new testing requirements, impacting operational costs.
The company is facing challenges in navigating a dynamic regulatory environment, which includes shifting state restrictions that narrow product sales opportunities.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

YCBD.A - cbdMD Inc
Q2 2026 cbdMD Inc Earnings Call
May 14, 2026 / 08:20PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon. Welcome to CBDMV, Inc.'s March 31st, 2026, second fiscal quarter of 2026 earnings call and update.

This afternoon, the company issued a press release that provided an overview of its first-quarter results, which followed the filing of its quarterly report on Form 10-Q.

Today's conference call is being recorded and will be available online, along with our earnings press release covering our financial results and non-GAAP presentation at cbdmd.com, in accordance with CBDMD's retention policies.

All participants on this call will be in a listen-only mode. The call will be followed by a question-and-answer session.

At this time, I'd like to turn the conference over to Brad Whitford, the company's Chief

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.